BIIB News 285.81 04/26/2014 00:24:41 Biogen Idec Inc (BIIB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biogen Idec Inc (BIIB) 285.81 $BIIB

Can Biogen Dethrone Baxter in Hemophilia?
Todd Campbell, The Motley Fool - Motley Fool - Fri Apr 25, 5:30PM CDT
Drugmakers like Biogen are enjoying a new wave of success as they usher next-generation therapies to market that are displacing prior treatments. Gilead has de-throned injectible drugs as the standard of care with a faster and better working...

SmarTrend Watching for Potential Rebound in Shares of Biogen Idec After 3.06% Loss
Comtex SmarTrend(R) - Fri Apr 25, 4:01PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $285.58 to a high of $296.74. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $286.48 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Biogen Idec to Potentially Rebound After Falling 3.06% Yesterday
Comtex SmarTrend(R) - Fri Apr 25, 4:00PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $285.58 to a high of $296.74. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $286.48 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

PharmaPoint: Crohn's Disease - Current and Future Players
M2 - Fri Apr 25, 9:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4n3bcj/pharmapoint) has announced the addition of the "PharmaPoint: Crohn's Disease - Current and Future Players" report to their offering. PharmaPoint: Crohn's Disease - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn's Disease Market. The report identifies and analyses the key companies shaping and driving the global Crohn's Disease market. The report provides insight into the competitive Crohn's Disease landscape, including new companies entering the market. Scope - Investigation of current and future market competition for Crohn's Disease - Competitor assessment - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of Crohn's Disease sector through market impact analysis, future market scenario and company analysis Key Topics Covered: - Tables & Figures - Introduction - Market Outlook - Current and Future Players - Appendix Companies Mentioned - Johnson & Johnson - AbbVie - UCB - Biogen Idec - Takeda - ChemoCentryx For more information visit http://www.researchandmarkets.com/research/4n...harmapoint

Quintiles enters into comprehensive clinical development partnership with Biogen Idec
M2 - Fri Apr 25, 6:01AM CDT
Biopharmaceutical company Quintiles revealed on Thursday the launch of a multi year strategic clinical development agreement with Biogen Idec (NasdaqGS:BIIB).

Why Xilinx Inc., Biogen Idec Inc., and Qualcomm Incorporated Are Today’s 3 Worst Stocks
John Divine, The Motley Fool - Motley Fool - Thu Apr 24, 7:04PM CDT
U.S. manufacturers are starting to hit their strides this spring, according to new data from the Census Bureau. Durable goods orders rose 2.6% in March from February, notably better than the 2% increase expected by Econoday; the strong demand is a...

Why Investors Should Love Biogen's Earnings Miss
Dan Carroll, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Big biotech  Biogen Idec has weathered the industry's storm in a rocky 2014. The stock's gained more than 9% despite the biotech sector's fall brought on by nervous investors concerned about the market's rally, and Biogen has plenty of room for...

Spectrum Pharma Candidate Gets Positive Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 4:50PM CDT
Spectrum Pharmaceuticals (SPPI) announced encouraging results from a phase II pivotal study on captisol-enabled melphalan.

Stock Market News for April 24, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 9:06AM CDT
Benchmarks ended lower on Wednesday following disappointing corporate results and economic data

Earnings Roundup: Biogen's Tecfidera Wins More Share
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 8:30AM CDT
Biogen remains a market leader in treating multiple sclerosis, an autoimmune disease that affects more than 1.1 million people in the U.S. and Europe. The company has launched a host of widely successful MS therapies over the past decade,...

Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:49AM CDT
Ambit Biosciences saw a big move last session, as the company’s shares fell by over 7% on the day

Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:44AM CDT
Prothena Corporation plc (PRTA) was a big mover last session, as the company saw its shares rally nearly 10.00% on the day.

Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership
Business Wire - Thu Apr 24, 7:00AM CDT
Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: BIIB) have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec's clinical development processes.

Biogen EPS misses, guides up
at Investor's Business Daily - Wed Apr 23, 5:49PM CDT
The biotech's Q1 EPS jumped 25% to $2.47, but missed views by 9 cents. Revenue rose 50.5% to $2.13 bil, above views for $2 bil. U.S. sales of MS drug Tecfidera were $460 mil vs. views of $413 mil. Nearly all individual product sales beat consensus....

Biogen Q1, Guidance Strong
at Investor's Business Daily - Wed Apr 23, 5:46PM CDT
Big-cap biotech Biogen Idec reported solid Q1 revenue early Wednesday and guided 2014 above Wall Street's expectations, but the stock rose just a fraction as biotechs had a bad day and Biogen revealed it's being probed by authorities. Biogen (BIIB)...

Why Biogen (BIIB) Stock Is Down Today
at The Street - Wed Apr 23, 12:55PM CDT
Biogen (BIIB) shares fall as Biotech ETF as takes a hit in trading today

Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 12:40PM CDT
Although Biogen (BIIB) missed earnings estimates, revenues surpassed expectations easily. The company also raised its guidance.

Interesting BIIB Put And Call Options For June 21st
at The Street - Wed Apr 23, 10:05AM CDT
Investors in Biogen Idec Inc saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options chain for the new June 21st contracts and identified one put...

Biogen Q1 Sales Beat Street, Guidance Strong
at Investor's Business Daily - Wed Apr 23, 9:11AM CDT
Big-cap biotech Biogen Idec (BIIB) reported solid Q1 revenue early Wednesday and guided 2014 above Wall Street's expectations, but the stock was down more than 1% in early trading in the stock market today. Biogen said revenue rose 50.5% over the...

Amgen's Q1 Earnings Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 8:40AM CDT
Amgen's first quarter results were disappointing with most of the products recording a sequential decline in sales.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 109

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 81

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 178

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 52

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 187

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 116

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 147

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 136

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 84

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading

Top 5 Most Recently Viewed Articles

Xtract One Technologies Partners with Manor ISD for Enhanced Security

Updated Category News Views 273

Xtract One Technologies Partners with Manor ISD for Enhanced Security Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) has recently entered into an agreement with Manor Independent School District (ISD) to solidify their security measures within the district. This collaboration aims to implement advanced security solutions designed to protect students, staff,...

Continue Reading
Bill Gates Explains His Views on Crypto and Investment Choices

Updated Category News Views 313

Bill Gates' Perspective on Cryptocurrencies Bill Gates, known for founding Microsoft, has shared his skepticism regarding cryptocurrencies, especially Bitcoin. His remarks often point to his belief that cryptocurrencies lack intrinsic value compared to other investments that produce tangible results. The Value of Tangible Investments In discussions, Gates has been clear...

Continue Reading
An In-Depth Look at Broadcom's Industry Standing and Competition

Updated Category News Views 267

Understanding Broadcom's Market Position In today's rapidly evolving business landscape, understanding the market dynamics within the semiconductor industry is crucial for investors and analysts alike. Broadcom (NASDAQ: AVGO) stands as a key player in this competitive arena. This article takes a closer look at Broadcom's market position against its competitors in the...

Continue Reading
European Central Bank Faces Challenges Amid Weak Growth Signs

Updated Category News Views 115

Indicators of Economic Strain in the Euro Zone After a series of interest rate cuts this year, the Eurozone faces significant economic challenges. Policymakers have expressed their concerns regarding persistently weak growth, exacerbated by potential U.S. trade tariffs. As inflation appears to be under control, the looming question is how these tariffs could adversely...

Continue Reading
5 Unopposed Tips for Donor Management Like a Pro

Updated Category Business Views 348

Essential Donor Management Tips for Non-Profit Success Being a non-profit organization manager can be challenging. If you are not dealing with funding and financial sustainability, you are likely to deal with donor retention and engagement. You are also likely to deal with attracting and retaining staff and volunteers. Your organization's reputation can also be put to the...

Continue Reading